LT - 2,2-DIMETHYL-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-PROPIONAMIDE, METHOD FOR PREPARING (6-AMINO-PYRIDIN-2-YL)-(1-METHYL-PIPERIDIN-4-YL)-METHANONE USING SAID COMPOUND, AND USE OF SAID COMPOUND IN THE PREPARATION OF LASMIDITAN
EN - 2,2-DIMETHYL-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-PROPIONAMIDE, METHOD FOR PREPARING (6-AMINO-PYRIDIN-2-YL)-(1-METHYL-PIPERIDIN-4-YL)-METHANONE USING SAID COMPOUND, AND USE OF SAID COMPOUND IN THE PREPARATION OF LASMIDITAN
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
| (51) |
INT.CL. |
C07D 401/06 |
(2006.01) |
|
|
C07D 401/06 |
(2013.01) |
|
|
A61K 31/444 |
(2006.01) |
|
|
A61P 25/06 |
(2018.01) |
|
|
A61P 25/06 |
(2006.01) |
Europos patentas
| (11) |
Patento numeris |
3994131 |
| (13) |
Dokumento rūšis |
T |
| (96) |
Europos patento paraiškos numeris |
20737114.7 |
|
Europos patento paraiškos padavimo data |
2020-06-30 |
| (97) |
Europos patento paraiškos paskelbimo data |
2022-05-11 |
| (45) |
Paskelbimo apie Europos patento išdavimą data |
2023-05-24
|
| (46) |
Apibrėžties vertimo paskelbimo data |
|
Tarptautinės paraiškos padavimo
| (86) |
Numeris |
PCT/EP2020/068358 |
|
Data |
2020-06-30 |
Tarptautinės paraiškos paskelbimo
| (87) |
Numeris |
WO 2021/001350 |
|
Data |
2021-01-07 |
Prioriteto paraiškos
| (30) |
Numeris |
Data |
Šalis |
|
201930607 |
2019-07-01
|
ES |
Išradėjai
| (72) |
ARE, Celeste , ES
SÁNCHEZ CASALS, Carles , ES
DOBARRO RODRÍGUEZ, Alicia , ES
|
Savininkas
| (73) |
Moehs Ibérica, S.L. ,
César Martinell i Brunet 12a, 08191 Rubí-Barcelona,
ES
|
Pavadinimas
| (54) |
2,2-DIMETHYL-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-PROPIONAMIDE, METHOD FOR PREPARING (6-AMINO-PYRIDIN-2-YL)-(1-METHYL-PIPERIDIN-4-YL)-METHANONE USING SAID COMPOUND, AND USE OF SAID COMPOUND IN THE PREPARATION OF LASMIDITAN |
| |
2,2-DIMETHYL-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-PROPIONAMIDE, METHOD FOR PREPARING (6-AMINO-PYRIDIN-2-YL)-(1-METHYL-PIPERIDIN-4-YL)-METHANONE USING SAID COMPOUND, AND USE OF SAID COMPOUND IN THE PREPARATION OF LASMIDITAN |
